InvestorsHub Logo

Jugas

01/30/17 8:16 PM

#693 RE: powerbattles #692

Agreed. Just shy of a 90% move on just under 25k shares, and at different buying levels all the way up. Not much was showing on L2 under .06, or .10 for that matter. Very thin.

Jugas

01/31/17 1:59 PM

#694 RE: powerbattles #692

Found some interesting stuff on QMDT. They signed a licensing deal with a company called VIRIDIS BIOPHARMA PVT. LTD in 2010, and it looks like it's still on-going.

https://www.lawinsider.com/contracts/55sHYLC5gQ0rNazsFvLVdn/quick-med-technologies/florida/2010-07-30

I went to the VIRIDIS BIOPHARMA PVT. website, which is current, and look what I found under their products:

http://viridisbiopharma.com/index.htm

Microfoam™ and Woundguard™

These innovative dressings, available as a polyurethene foam (Microfoam™) or a 12 ply cotton gauze (Woundguard™), prevent bacterial penetration and inhibits growth within wound dressings. They are based on the cutting edge, patented non-leaching antimicrobial NIMBUS® Technology from Quick-Med Technologies, USA, which TIME magazine called one of the ‘10 Best Discoveries of 2006’. NIMBUS® is based on non-toxic, long chain polymers with high charge density that provide superior efficacy via a physical action on microbes. By destroying bacteria at the cellular level, NIMBUS® eliminates the risk of developing drug resistance. The technology is highly effective against a multitude of bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE).


http://viridisbiopharma.com/products/dressings.htm

And found this too:

Quick-Med Technologies

Quick-Med Technologies, Inc is a life sciences company focused on developing proprietary, broad-based technologies for infection prevention and control in the consumer and healthcare markets. They developed the patented NIMBUS® technology which is licensed by Viridis for the manufacture of Microfoam™ and Woundguard™.